Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy

BACKGROUND: The mechanisms by which chronic hepatitis B is completely resolved through antiviral therapy are unknown, and the contribution of acquired T cell immunity to hepatitis B surface antigen (HBsAg) seroclearance has not been investigated. Therefore, we measured the T-cell responses to core a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Minfeng, Ma, Shiwu, Hu, Xiaoxiong, Zhou, Bin, Zhang, Junchang, Chen, Jinjun, Wang, Zhanhui, Sun, Jian, Zhu, Xiaolin, Abbott, William, Hou, Jinlin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049122/
https://www.ncbi.nlm.nih.gov/pubmed/21320337
http://dx.doi.org/10.1186/1743-422X-8-69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049122/
https://www.ncbi.nlm.nih.gov/pubmed/21320337
http://dx.doi.org/10.1186/1743-422X-8-69

Ejemplares similares